RICCARDI, CLAUDIA
 Distribuzione geografica
Continente #
AS - Asia 2.384
EU - Europa 1.731
NA - Nord America 1.684
SA - Sud America 329
AF - Africa 64
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.193
Nazione #
US - Stati Uniti d'America 1.632
SG - Singapore 1.009
RU - Federazione Russa 735
IT - Italia 567
CN - Cina 498
VN - Vietnam 463
BR - Brasile 277
HK - Hong Kong 175
DE - Germania 101
FR - Francia 82
GB - Regno Unito 45
IN - India 43
NL - Olanda 40
JP - Giappone 37
KR - Corea 35
FI - Finlandia 30
CA - Canada 29
AR - Argentina 26
ES - Italia 25
CI - Costa d'Avorio 24
BD - Bangladesh 22
IE - Irlanda 18
SE - Svezia 16
BE - Belgio 15
MX - Messico 13
PH - Filippine 12
PL - Polonia 12
AT - Austria 11
ID - Indonesia 11
IQ - Iraq 11
MA - Marocco 11
ZA - Sudafrica 11
TH - Thailandia 10
EC - Ecuador 8
CO - Colombia 7
PK - Pakistan 6
UA - Ucraina 6
GR - Grecia 5
LT - Lituania 5
TR - Turchia 5
TW - Taiwan 5
AE - Emirati Arabi Uniti 4
JO - Giordania 4
KE - Kenya 4
MY - Malesia 4
BH - Bahrain 3
EG - Egitto 3
KG - Kirghizistan 3
LB - Libano 3
NP - Nepal 3
RO - Romania 3
SA - Arabia Saudita 3
UY - Uruguay 3
UZ - Uzbekistan 3
CL - Cile 2
CZ - Repubblica Ceca 2
DZ - Algeria 2
EE - Estonia 2
HN - Honduras 2
IL - Israele 2
JM - Giamaica 2
NI - Nicaragua 2
PT - Portogallo 2
PY - Paraguay 2
SY - Repubblica araba siriana 2
TZ - Tanzania 2
AL - Albania 1
BO - Bolivia 1
CR - Costa Rica 1
CW - ???statistics.table.value.countryCode.CW??? 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GY - Guiana 1
HR - Croazia 1
HU - Ungheria 1
IR - Iran 1
IS - Islanda 1
KW - Kuwait 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
MD - Moldavia 1
ML - Mali 1
MN - Mongolia 1
MO - Macao, regione amministrativa speciale della Cina 1
MQ - Martinica 1
MT - Malta 1
NO - Norvegia 1
OM - Oman 1
PE - Perù 1
QA - Qatar 1
RS - Serbia 1
RW - Ruanda 1
SI - Slovenia 1
SN - Senegal 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
VE - Venezuela 1
ZM - Zambia 1
ZW - Zimbabwe 1
Totale 6.193
Città #
Singapore 492
San Jose 215
Moscow 196
Chandler 186
Hong Kong 167
Ashburn 155
Beijing 154
Naples 143
Hefei 134
Ho Chi Minh City 129
Hanoi 106
Napoli 96
Santa Clara 94
Lauterbourg 45
Dong Ket 40
Los Angeles 39
Millbury 36
The Dalles 34
Munich 29
Rome 27
Tokyo 27
Seoul 26
Amsterdam 25
Lawrence 25
Nanjing 25
New York 25
Des Moines 24
São Paulo 24
Boston 23
Buffalo 23
Council Bluffs 23
Redondo Beach 23
Milan 22
Da Nang 19
Dallas 17
Nuremberg 17
Madrid 14
Frankfurt am Main 12
Houston 12
Kochi 12
Princeton 12
Turku 11
Wilmington 11
Belo Horizonte 10
Düsseldorf 10
Rio de Janeiro 10
Warsaw 10
Brussels 9
Ottawa 9
Seattle 9
Stockholm 9
Casablanca 8
Catania 8
Haiphong 8
Hải Dương 8
Lappeenranta 8
London 8
Orem 8
Redwood City 8
Vienna 8
Guangzhou 7
Manchester 7
Torre del Greco 7
Turin 7
Atlanta 6
Biên Hòa 6
Can Tho 6
Caserta 6
Chennai 6
Chicago 6
Denver 6
Montreal 6
Norwalk 6
Salerno 6
Bangkok 5
Boscoreale 5
Dhaka 5
Fairfield 5
Helsinki 5
Johannesburg 5
Thái Nguyên 5
Toronto 5
Villafranca Tirrena 5
Woodbridge 5
Baghdad 4
Bexley 4
Brasília 4
Cinisello Balsamo 4
Curitiba 4
Fisciano 4
Forlì 4
Goiânia 4
Guarulhos 4
Guayaquil 4
Jiaxing 4
Las Vegas 4
Mexico City 4
Nanchang 4
Ninh Bình 4
Osasco 4
Totale 3.319
Nome #
BENZODIFURAN DERIVATIVES AS POTENTIAL ANTIPROLIFERATIVE AGENTS: POSSIBLE CORRELATION BETWEEN THE BIOACTIVITY AND THEIR AGGREGATION PROPERTIES 177
"dressing up" an Old Drug: An Aminoacyl Lipid for the Functionalization of Ru(III)-Based Anticancer Agents 166
Self-assembly of thyminyl l-tryptophanamide (TrpT) building blocks for the potential development of drug delivery nanosystems 164
Antiproliferative effects of ruthenium-based nucleolipidic nanoaggregates in human models of breast cancer in vitro: insights into their mode of action. 164
Exploring cellular uptake, accumulation and mechanism of action of a cationic Ru-based nanosystem in human preclinical models of breast cancer 158
Stability is not everything the case of the cyclization of the thrombin binding aptamer 157
Ru(III) complexes for anticancer therapy: the importance of being nucleolipidic 145
On the pH-Modulated Ru-Based Prodrug Activation Mechanism 145
Anticancer activity of a cationic Ru-based nanosystem in a human xenograft model of breast cancer 145
Fighting the Huntington’s Disease with a G-Quadruplex-Forming Aptamer Specifically Binding to Mutant Huntingtin Protein: Biophysical Characterization, In Vitro and In Vivo Studies 140
Preclinical validation of an original Ru(III)-based nanosystem in human models of breast cancer 137
Fluorescence Sensing Using DNA Aptamers in Cancer Research and Clinical Diagnostics 136
Bioengineered lipophilic Ru(III) complexes as potential anticancer agents 135
Insights into the G-rich VEGF-binding aptamer V7t1: when two G-quadruplexes are better than one! 135
Nucleolipidic-based liposomes effectively deliver a Ru(III) complex across cell membranes to nuclei promoting in concert apoptosis and autophagy in human models of breast cancer 135
Truncated Analogues of a G-Quadruplex-Forming Aptamer Targeting Mutant Huntingtin: Shorter Is Better! 133
A first-in-class and a fished out anticancer platinum compound:: Cis -[PtCl2(NH3)2] and cis -[PtI2(NH3)2] compared for their reactivity towards DNA model systems 133
Exploring the conformational behaviour and aggregation properties of lipid-conjugated AS1411 aptamers 131
G-quadruplex-based aptamers against protein targets in therapy and diagnostics 128
A terminal functionalization strategy reveals unusual binding abilities of anti-thrombin anticoagulant aptamers 126
Directing in Vitro Selection towards G‐quadruplex‐forming Aptamers to Inhibit HMGB1 Pathological Activity 126
Tuning the polymorphism of the anti-VEGF G-rich V7t1 aptamer by covalent dimeric constructs 126
Benzodifurans for biomedical applications: BZ4, a selective anti-proliferative and anti-amyloid lead compound 122
Synthesis, DNA binding studies, and antiproliferative activity of novel Pt(II)-complexes with an L-alanyl-based ligand 120
Fluorescent Thrombin Binding Aptamer-Tagged Nanoparticles for an Efficient and Reversible Control of Thrombin Activity 118
G-Quadruplex Forming Oligonucleotides as Anti-HIV Agents 117
Anti-VEGF DNA-based aptamers in cancer therapeutics and diagnostics 117
Disentangling the Structure-Activity Relationships of Naphthalene Diimides as Anticancer G-Quadruplex-Targeting Drugs 116
Affinity chromatography-based assays for the screening of potential ligands selective for G-quadruplex structures 112
Fine-tuning the properties of the thrombin binding aptamer through cyclization: Effect of the 5′-3′ connecting linker on the aptamer stability and anticoagulant activity 111
Safety and efficacy evaluation in vivo of a cationic nucleolipid nanosystem for the nanodelivery of a ruthenium(III) complex with superior anticancer bioactivity 111
Exploring the Binding of Natural Compounds to Cancer-Related G-Quadruplex Structures: From 9,10-Dihydrophenanthrenes to Their Dimeric and Glucoside Derivatives 109
Insights into the Small Molecule Targeting of Biologically Relevant G-Quadruplexes: An Overview of NMR and Crystal Structures 109
Triple Negative Breast Cancer Preclinical Therapeutic Management by a Cationic Ruthenium-Based Nucleolipid Nanosystem 109
Anticancer Ruthenium(III) Complexes and Ru(III)-Containing Nanoformulations: An Update on the Mechanism of Action and Biological Activity 107
AS1411-decorated niosomes as effective nanocarriers for Ru(III)-based drugs in anticancer strategies 107
G-quadruplex-based aptamers targeting human thrombin: Discovery, chemical modifications and antithrombotic effects 103
Selective light-up of dimeric G-quadruplex forming aptamers for efficient VEGF165 detection 102
Dimeric and Multimeric DNA Aptamers for Highly Effective Protein Recognition 101
RuIII Complexes for Anticancer Therapy: The Importance of Being Nucleolipidic 99
Synthesis, antiproliferative activity, and DNA binding studies of nucleoamino acid-containing Pt(II) complexes 98
Charge-transfer interactions stabilize g-quadruplex-forming thrombin binding aptamers and can improve their anticoagulant activity 91
Synthesis and characterization of multifunctional nanovesicles composed of POPC lipid molecules for nuclear imaging 91
Design, synthesis and characterization of cyclic nu172 analogues: A biophysical and biological insight 90
Modular symmetric ligands for selective recognition of cancer-relevant G-quadruplexes 85
When annealing is detrimental: The case of HMGB1-targeting G-quadruplex aptamers 84
Design, Synthesis, and Characterization of an Amphiphilic Lipoic Acid-Based Ru(III) Complex as a Versatile Tool for the Functionalization of Different Nanosystems 76
Investigating the Interaction of an Anticancer Nucleolipidic Ru(III) Complex with Human Serum Proteins: A Spectroscopic Study 73
Natural compounds from Juncus plants interacting with telomeric and oncogene G-quadruplex structures as potential anticancer agents 73
Ferroptosis Among the Antiproliferative Pathways Activated by a Lipophilic Ruthenium(III) Complex as a Candidate Drug for Triple-Negative Breast Cancer 69
Metal-Based Complexes in Cancer 68
Understanding the biological activities of vitamin d in type 1 neurofibromatosis: New insights into disease pathogenesis and therapeutic design 66
Probing naphthalene diimide and 3-hydroxypropylphosphate as end-conjugating moieties for improved thrombin binding aptamers: Structural and biological effects 62
Nanoparticle-guided brain drug delivery: Expanding the therapeutic approach to neurodegenerative diseases 58
Covalently linked dimers of a G-quadruplex-forming aptamer as HMGB1 inhibitors 46
Nucleic acid-based aptamers in therapeutics and diagnostics 43
G-Quadruplex-Forming Aptamers as Selective Inhibitors of HMGB1 Protein: a Journey from Design to Their Functional Validation 17
When the Position of Pendant Groups Makes the Difference in G-Quadruplex Behavior: The Case of Bis-Conjugated Thrombin-Binding Aptamers 7
Totale 6.329
Categoria #
all - tutte 19.252
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.252


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202143 0 0 0 0 0 0 0 0 0 0 1 42
2021/2022234 0 0 1 7 5 7 7 10 37 10 66 84
2022/2023471 45 51 8 31 52 51 14 51 68 47 37 16
2023/2024334 11 68 43 27 17 26 24 34 4 0 45 35
2024/20251.657 75 98 14 33 28 105 150 109 83 174 623 165
2025/20263.093 328 346 420 278 557 99 270 182 366 201 46 0
Totale 6.329